Application Of Umbilical Cord Blood Transfusion In  Post-Covid-19 Anaemic Patients

Biplabendu  Talukdar; Priyodarshi Sengupta; Niranjan Bhattacharya; Rita Ghosh

doi:10.48165/

Authors

Biplabendu Talukdar Department of Biochemistry and Biophysics, Kalyani University. Nadia - 741235, West Bengal (India)
Priyodarshi Sengupta Department of Regenerative Medicine and Translational Science (RMTS), Carmichael Hospital, School of Tropical Medicine (STM) and Hospital, Kolkata – 700 773, West Bengal (India)
Niranjan Bhattacharya Department of Regenerative Medicine and Translational Science (RMTS), Carmichael Hospital, School of Tropical Medicine (STM) and Hospital, Kolkata – 700 773, West Bengal (India)
Rita Ghosh Department of Biochemistry and Biophysics, Kalyani University. Nadia - 741235, West Bengal (India)

DOI:

https://doi.org/10.48165/

Keywords:

Anaemia, covid-19, umbilical cord blood transfusion

Abstract

The practice of discarding Umbilical Cord Blood (UCB) is very common in 3rd world countries but still a major issue in developing countries like India. UCB transfusion is done in post-Covid patients to treat anaemia, and there are various ethical issues which have to be mitigated. In this study we compared the clinical symptoms of people who received UCB for the treatment of anaemia and the people who received other standard of care for anaemia after post-Covid 19 infections. All patients were diagnosed as Covid-19 by RT-PCR test results. Symptomatic patients with complete blood count report suggestive of anaemia were included in our study. UCB was collected aseptically from surgical operation theatre. Available group matched patients were selected for transfusion after taken proper consent. All patients were followed up for consecutive four months. Results showed that the patients with cord blood transfusion recovered earlier than the patients managed by standard of care.

Downloads

Download data is not yet available.

References

Bhattacharya N. 2006a. Placental umbilical cord whole blood transfusion to combat anaemia in the background of tuberculosis and emaciation and its potential role as an immuno-adjuvant therapy for the under-resourced people of the world. Clinical and Experimental Obstetrics & Gynaecology, 33(2): 99-104.

Bhattacharya N. 2006b. Spontaneous transient rise of CD34 cells in peripheral blood after 72 hours in patients suffering from advanced malignancy with anaemia: Effect and prognostic implications of treatment with placental umbilical cord whole blood transfusion. European Journal of Gynaecological Oncology, 27(3): 286-290.

Bhattacharya, N. 2005a. Placental umbilical cord blood transfusion in transfusion-dependent beta thalassemic patients: A preliminary communication. Clinical and Experimental Obstetrics & Gynaecology, 32(2): 102-106.

Bhattacharya, N. 2005b. Placental umbilical cord whole blood transfusion: A safe and genuine blood substitute for patients of the under-resourced world at emergency. Journal of the American College of Surgeons, 200(4): 557-563.

Bhattacharya, N. 2006c. A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anaemia and emaciation. Clinical and Experimental Obstetrics & Gynaecology, 33(2): 117-121.

Umbilical cord blood transfusion in post-Covid-19 anaemic patients 175

Bhattacharya, N. 2006d. A preliminary study of placental umbilical cord whole blood transfusion in under resourced patients with malaria in the background of anaemia. Malaria Journal, 5(1): 1-5. Bhattacharya, N. 2006e. A study of placental umbilical cord whole blood transfusion in 72 patients with anaemia and emaciation in the background of cancer. European Journal of Gynaecological Oncology, 27(2): 155-161.

Bhattacharya, N. 2006f. Placental umbilical cord blood transfusion: A novel method of treatment of patients with malaria in the background of anaemia. Clinical and Experimental Obstetrics & Gynaecology, 33(1): 39-43.

Bhattacharya, N. 2006g. Placental umbilical cord blood transfusion: A new method of treatment of patients with diabetes and microalbuminuria in the background of anaemia. Clinical and Experimental Obstetrics & Gynaecology, 33(3): 164-168.

Bhattacharya, N. 2006h. Spontaneous transient rise of CD34 cells in peripheral blood after 72 hours in patients suffering from advanced malignancy with anaemia: Effect and prognostic implications of treatment with placental umbilical cord whole blood transfusion. European Journal of Gynaecological Oncology, 27(3): 286-290.

Bhattacharya, N., Mukherijee, K., Chettri, M.K., Banerjee, T., Mani, U. and Bhattacharya, S. 2001. A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of foetal haemoglobin supply in different indications of blood transfusion. Clinical and Experimental Obstetrics & Gynaecology, 28(1): 47-52.

Cotoraci, C., Ciceu, A., Sasu, A. and Hermenean, A. 2021. Natural antioxidants in anemia treatment. International Journal of Molecular Sciences, 22(4): 1883. [doi: 10.3390/ijms22041883]. Delivoria-Padopoulos. M., Roncevic, N.P. and Oski, F.A. 1971. Post-natal changes in oxygen transport of term, premature and sick infants: The role of red cell 2,3 diphosphoglycerate and adult hemoglobin. Paediatric Research, 5(6): 235-245.

Halbrecht, J. 1939. Fresh and stored placental blood. The Lancet, 2: 1263. [doi: 10.1016/S0140- 6736(00)74023-2].

Hassall, O., Bedu-Addo, G., Adarkwa, M., Danso, K. and Bates, I. 2003. Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries. The Lancet, 361(9358): 678-679.

Killmartin, J.V. 1976. Interaction of haemoglobin with proteins CO2 and 2,3 diphosphoglycerate, British Medical Bulletin, 32: 209-212.

McNanley, T. and Woods, J. 2008. Placental Physiology. The Global Library of Women's Medicine, 10(4): [DOI 10.3843/GLOWM.10195].

Oski, A. and Naiman, J.L. 1982. Hematologic Problems in the New Born (3rd edn.). WB Saunders, Philadelphia, USA.

Sarvaria, A., Jawdat, D., Madrigal, J.A. and Saudemont, A. 2017. Umbilical cord blood natural killer cells, their characteristics and potential clinical applications. Frontiers in Immunology, 8: 329. [https://doi.org/10.3389/fimmu.2017.00329].

Suvvari, T.K., Kutikuppala, L.V.S., Tsagkaris, C., Corriero, A.C. and Kandi, V. 2021. Post-Covid-19 complications: Multisystemic approach. Journal of Medical Virology, 93(12): 6451-6455. Suvvari, T.K., Simhachalam Kutiuppala, L.V., Babu, G.K. and Jadhav, M. 2020. Understanding the unusual viral outbreak: Coronavirus disease 2019. Journal of Current Research in Science and Medicine, 6: 3-10.

WHO. 2009. Screening donated blood for transfusion - transmissible infections recommendations: Blood screening, quarantine and release. World Health Organization, Geneva, Switzerland. [https://www.ncbi.nlm.nih.gov/books/NBK142991/].

Zhang, C., Qin, L., Li, K., Wang, Q., Zhao, Y., Xu, B. and Zhang, Y. 2020. A novel scoring system for prediction of disease severity in Covid-19. Frontiers in Cellular and Infection Microbiology, 10: 318. [https://doi.org/10.3389/fcimb.2020.00318].